A phase 1 dose-escalation study of GCC19CART: A novel CAR T-cell therapy for metastatic colorectal cancer in the United States.

Authors: Bridget P. Keenan, Christopher Hanyoung Lieu, Marwan Fakih, Alan P. Venook, Dongqi Chen, Eric Keith Rowinsky, Victor Lu, Lei Xiao, Benjamin L. Schlechter

Published: 2025-01-27

DOI: 10.1200/jco.2025.43.4_suppl.175

Source: Full article


Abstract

175